| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biogen Inc. (BIIB) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. BIIB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 31.0K | $6.20M | - | |
| Dir | 24.3K | $4.87M | - | |
| Dir | 13.7K | $2.74M | - | |
| Dir | 9.8K | $1.95M | - | |
| Dir | 8.9K | $1.77M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2015 | Sherwin Stephen A | Director | Sale+OE | 6,000 | $409.67 | $2,458,020.00 | -59.1% | |
| Mar 9, 2015 | Rowinsky Eric K | Director | Sale+OE | 4,666 | $417.23 | $1,946,795.18 | -29.2% | |
| Mar 2, 2015 | Scangos George A77 | Chief Executive Officer | Sell | 825 | $410.67 | $338,802.75 | -1.8% | |
| Mar 2, 2015 | Sandrock Alfred69 | Grp SVP, Chief Medical Officer | Sell | 3,174 | $409.49 | $1,299,714.73 | -5.7% | |
| Feb 19, 2015 | Scangos George A77 | Chief Executive Officer | Sell | 537 | $401.04 | $215,358.48 | -1.1% | |
| Feb 17, 2015 | Scangos George A77 | Chief Executive Officer | Sell | 825 | $389.11 | $321,015.75 | -1.7% | |
| Feb 17, 2015 | Holtzman Steven H | EVP Corporate Development | Sell | 2,128 | $389.11 | $828,026.08 | -33.0% | |
| Feb 17, 2015 | Dipietro Kenneth | EVP Human Resources | Sell | 1,188 | $389.11 | $462,262.68 | -59.7% | |
| Feb 17, 2015 | Sandrock Alfred69 | Grp SVP, Chief Medical Officer | Sell | 418 | $389.11 | $162,647.98 | -2.7% | |
| Feb 10, 2015 | Sandrock Alfred69 | Grp SVP, Chief Medical Officer | Sell | 1,143 | $398.11 | $455,038.99 | -1.9% |